India’s Bioeconomy surges from $10 billion to $195 billion in a decade, Registers 17–18% Annual Growth: Dr Jitendra Singh

1. At a Glance

• Bioeconomy = economic activity from biological resources & biotech (pharma, bio-agri, bio-industrial, bio-IT/services). India's bioeconomy grew from ~$10 bn (2014) to $195.3 bn (2025), ~5% of GDP [1][3].
• Announced by Dr Jitendra Singh, MoS (IC) Science & Technology, at BIRAC 14th Foundation Day, 19 March 2026, alongside release of IBER 2026 [1].
• Target: $300 bn bioeconomy by 2030; anchored by the BioE3 Policy (Cabinet, Aug 2024) [1][2][4].
• Relevant for GS-III (Economy, Science & Tech, Biotechnology) and Prelims schemes/agencies.

2. Why in the News

• On 19 March 2026, at BIRAC's 14th Foundation Day, the Minister announced the bioeconomy crossed $195.3 bn in 2025, growing 17–18% YoY from $165.75 bn in 2024 [1][3].
• India Bioeconomy Report (IBER) 2026 and BIRAC Impact Report released the same day [1].
• Reinforces the BioE3 Policy rollout (first DBT-BIRAC joint calls received >2,000 proposals) [2].

3. Background & Evolution

• 2012: BIRAC set up as a not-for-profit Section 8 PSU under Department of Biotechnology (DBT), Ministry of Science & Technology [1].
• 2014: India's bioeconomy ~$10 bn [3].
• 2022: National Biotech Development Strategy; bioeconomy crosses $100 bn.
• 24 Aug 2024: Union Cabinet approved BioE3 (Biotechnology for Economy, Environment & Employment) Policy [5].
• 2024: Bioeconomy at $165.75 bn; 2025: $195.3 bn (~18% CAGR) [3][6].
• 2030 target: $300 bn [4].

4. Core Static Facts

• Implementing ministry: Ministry of Science & Technology → Department of Biotechnology (DBT); nodal industry body: BIRAC [1][5].
• Policy: BioE3 Policy, 2024 — "Fostering High Performance Biomanufacturing" [2][5].
• BioE3 thematic sectors (6): (i) high-value bio-based chemicals, biopolymers & enzymes; (ii) smart proteins & functional foods; (iii) precision biotherapeutics; (iv) climate-resilient agriculture; (v) carbon capture & utilisation; (vi) marine & space research [2].
• Key infra under BioE3: Biomanufacturing & Bio-AI hubs; Biofoundry [2].
• Numbers: $195.3 bn (2025); ~4.8–5% of GDP; CAGR ~18%; >11,800 biotech startups; $300 bn target by 2030 [1][3].
• Alignment: Net-Zero commitment; Mission LiFE [2].

5. Multi-Dimensional Analysis

Economic

• 19.5× growth in a decade; ~5% GDP contribution; supports Viksit Bharat 2047 ambition [1][3].
• 11,800+ startups → jobs in tier-2/3 cities via Bio-Incubators [1].

Scientific / Technological

• Convergence of biotech + AI ("Bio-AI hubs") under BioE3 [2].
• Focus on smart proteins, precision biotherapeutics, synthetic biology [2].

Environmental

• Sustainable biomanufacturing replaces fossil-based inputs; supports Net Zero by 2070 and circular economy [2].
• Carbon capture & utilisation as a dedicated theme [2].

Administrative / Governance

• DBT-BIRAC joint funding calls; first round drew 2,000+ proposals [2].
• Cross-ministerial play: DST, MoEFCC, Agriculture, MoES (marine), DoS (space research theme) [2].

Strategic

• Positions India as a global biomanufacturing hub countering reliance on Chinese APIs and bio-inputs [2][5].

6. Recent Developments (last 12-18 months)

• 24 Aug 2024: Cabinet approves BioE3 Policy [5].
• 2024–25: Bioeconomy rises $165.75 bn → $195.3 bn (~18%) [3][6].
• 19 Mar 2026: IBER 2026 + BIRAC Impact Report released at BIRAC 14th Foundation Day [1].
• DBT-BIRAC joint calls under BioE3 received >2,000 proposals [2].

7. Prelims Hooks

• BioE3 stands for Biotechnology for Economy, Environment & Employment [5].
• BioE3 Policy approved by Union Cabinet in August 2024 [5].
• BIRAC = Biotechnology Industry Research Assistance Council; Section 8 not-for-profit PSU under DBT, est. 2012 [1].
• India's bioeconomy: $10 bn (2014) → $195.3 bn (2025) [3].
• Contribution to GDP: ~4.8–5% (IBER 2026) [1].
• CAGR: ~17–18% [1].
• Target: $300 bn by 2030 [4].
• Biotech startups in India: >11,800 [1].
• Implementing nodal agency: Department of Biotechnology (DBT), Ministry of Science & Technology [5].
• BioE3 six thematic areas include smart proteins, precision biotherapeutics, marine & space research [2].
• BioE3 establishes Biomanufacturing & Bio-AI hubs and a Biofoundry [2].
• BioE3 aligned with Net-Zero and Mission LiFE [2].
• IBER = India Bioeconomy Report; 2026 edition released 19 March 2026 [1].
• Minister: Dr Jitendra Singh, MoS (IC) Science & Technology [1].

8. Mains Relevance

• GS-III: Science & Technology — developments & applications; Indian Economy — growth, employment.
• Syllabus: "Achievements of Indians in S&T; indigenisation of technology"; "Awareness in biotechnology".
• Possible stems: 1. "India's BioE3 Policy marks a paradigm shift from product-led to platform-led biotech growth. Examine." (250 w) 2. "Discuss how India's bioeconomy can become a $300 bn engine by 2030. What are the structural bottlenecks?" (250 w) 3. "Sustainable biomanufacturing is central to India's Net-Zero pathway. Critically evaluate." (150 w)

9. Related Topics to Study Next

• BIRAC & DBT schemes (BIG, SPARSH, BIPP) — funding ecosystem.
• National Biopharma Mission (i3 programme) — predecessor flagship.
• Genome India Project — converging genomics frontier.
• PLI for Bulk Drugs/Medical Devices — manufacturing complementarity.
• Mission LiFE & Net-Zero 2070 — sustainability anchor.
• National Quantum Mission / IndiaAI Mission — Bio-AI convergence.
• Biological Diversity (Amendment) Act, 2023 — access-benefit sharing for bio-resources.
• Startup India / Atal Innovation Mission — startup pipeline feeder.

10. Common Errors / Trap Areas

• BIRAC is under DBT (Ministry of S&T), NOT MoEFCC or MoHFW.
• BioE3 was approved in August 2024, not 2023; it is a Cabinet-approved policy, not an Act.
• IBER is published by DBT-BIRAC, not NITI Aayog.
• "Bioeconomy" ≠ "biotech sector alone"; it spans bio-pharma, bio-agri, bio-industrial, bio-IT/services.
• Bioeconomy is ~5% of GDP, not 5% of manufacturing — easy MCQ trap.
• 2030 target is $300 bn, not $500 bn (the latter is the broader Viksit Bharat biotech vision).